GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (OTCPK:ACOGF) » Definitions » Dividend Yield %

Alpha Cognition (Alpha Cognition) Dividend Yield % : 0.00% (As of Jun. 10, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Dividend Yield %?

As of today (2024-06-10), the Trailing Annual Dividend Yield of Alpha Cognition is 0.00%.

The historical rank and industry rank for Alpha Cognition's Dividend Yield % or its related term are showing as below:

ACOGF's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.66
* Ranked among companies with meaningful Dividend Yield % only.

Alpha Cognition's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00.

As of today (2024-06-10), the Forward Dividend Yield % of Alpha Cognition is 0.00%.

Alpha Cognition's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Alpha Cognition Dividend Yield % Historical Data

The historical data trend for Alpha Cognition's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Dividend Yield % Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Dividend Yield %
- - - -

Alpha Cognition Quarterly Data
Jan20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alpha Cognition's Dividend Yield %

For the Biotechnology subindustry, Alpha Cognition's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Cognition's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Dividend Yield % falls into.



Alpha Cognition Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Alpha Cognition  (OTCPK:ACOGF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Alpha Cognition Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Alpha Cognition's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Cognition (Alpha Cognition) Business Description

Traded in Other Exchanges
Address
301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2
Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.